Jasper Therapeutics logo

Jasper Therapeutics Share Price Today

(NASDAQ: JSPR)

Jasper Therapeutics share price is $5.68 & ₹493.98 as on 6 Mar 2025, 2.30 'hrs' IST

$5.68

0.15

(2.71%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Jasper Therapeutics share price in Dollar and Rupees. Guide to invest in Jasper Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Jasper Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Jasper Therapeutics share price movements

  • Today's Low: $5.58
    Today's High: $5.82

    Day's Volatility :4.12%

  • 52 Weeks Low: $4.55
    52 Weeks High: $31.01

    52 Weeks Volatility :85.33%

Jasper Therapeutics (JSPR) Returns

PeriodJasper Therapeutics IncIndex (Russel 2000)
3 Months
-74.31%
0.0%
6 Months
-71.12%
0.0%
1 Year
-79.44%
0.0%
3 Years
-82.5%
-11.6%

Jasper Therapeutics (JSPR) Key Statistics

in dollars & INR

Previous Close
$5.53
Open
$5.65
Today's High
$5.82
Today's Low
$5.58
Market Capitalization
$83.0M
Today's Volume
$85.5K
52 Week High
$31.01
52 Week Low
$4.55
Revenue TTM
$0.0
EBITDA
$-74.9M
Earnings Per Share (EPS)
$-4.89
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-101.73%

How to invest in Jasper Therapeutics Stock (JSPR) from India?

It is very easy for Indian residents to invest directly in Jasper Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Jasper Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Jasper Therapeutics or JSPR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Jasper Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Jasper Therapeutics shares which would translate to 0.153 fractional shares of Jasper Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Jasper Therapeutics, in just a few clicks!

Returns in Jasper Therapeutics (JSPR) for Indian investors in Rupees

The Jasper Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Jasper Therapeutics investment value today

Current value as on today

₹26,078

Returns

₹73,922

(-73.92%)

Returns from Jasper Therapeutics Stock

₹78,885 (-78.88%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Jasper Therapeutics (JSPR)

-38%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Jasper Therapeutics Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Jasper Therapeutics

  • Soleus Capital Management, L.P.

    9.96%

  • Velan Capital Investment Management LP

    9.56%

  • The Carlyle Group Inc

    7.11%

  • Qiming U.S. Ventures Management, LLC

    6.19%

  • BlackRock Inc

    5.39%

  • BRAIDWELL LP

    4.76%

Analyst Recommendation on Jasper Therapeutics

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Jasper Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
11
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Jasper Therapeutics Stock (JSPR)

What analysts predicted

Upside of 945.77%

Target:

$59.40

Current:

$5.68

Insights on Jasper Therapeutics Stock (Ticker Symbol: JSPR)

  • Price Movement

    In the last 3 months, JSPR stock has moved down by -74.3%
  • JSPR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 140.1%
  • JSPR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 129.6%

Jasper Therapeutics Technicals Summary

Sell

Neutral

Buy

Jasper Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Jasper Therapeutics (JSPR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Jasper Therapeutics Inc logo
-10.95%
-71.12%
-79.44%
-82.5%
-95.49%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Jasper Therapeutics Inc logo
0.51
NA
NA
-5.66
-1.02
-0.55
NA
4.11
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Jasper Therapeutics Inc logo
Buy
$83.0M
-95.49%
0.51
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Jasper Therapeutics

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and conditioning regimens for stem cell transplantation. In addition, it is also developing stem cell transplants for rare diseases such as sickle cell disease, fanconi anemia, chronic granulomatous diseases, and GATA2 MDS, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.
Organization
Jasper Therapeutics
Employees
0
CEO
Mr. Ronald A. Martell
Industry
Miscellaneous

Management People of Jasper Therapeutics

NameTitle
Mr. Ronald A. Martell
President, CEO & Director
Mr. Jeetinder Singh Mahal M.B.A.
Chief Operating Officer
Dr. Edwin Jonathan Tucker M.D.
Chief Medical Officer
Mr. David Ku M.D.
Vice President of Corporate Development, Portfolio Strategy & Management
Mr. Matthew Ford
Vice President of Human Resources
Dr. Wendy Pang M.D., Ph.D.
Senior Vice President of Research & Translational Medicine
Dr. Luca Di Noto Ph.D.
Senior Vice President of Technical Operations
Ms. Patricia Carlos
Senior Vice President of Regulatory Affairs & Quality

Important FAQs about investing in JSPR Stock from India :

What is Jasper Therapeutics share price today?

Jasper Therapeutics share price today stands at $5.68, Open: $5.65 ; Previous Close: $5.53 ; High: $5.82 ; Low: $5.58 ; 52 Week High: $31.01 ; 52 Week Low: $4.55.

The stock opens at $5.65, after a previous close of $5.53. The stock reached a daily high of $5.82 and a low of $5.58, with a 52-week high of $31.01 and a 52-week low of $4.55.

Can Indians buy Jasper Therapeutics shares?

Yes, Indians can invest in the Jasper Therapeutics (JSPR) from India.

With INDmoney, you can buy Jasper Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Jasper Therapeutics at zero transaction cost.

How can I buy Jasper Therapeutics shares from India?

It is very easy to buy Jasper Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Jasper Therapeutics (JSPR) be purchased?

Yes, you can buy fractional shares of Jasper Therapeutics with INDmoney app.

What are the documents required to start investing in Jasper Therapeutics stocks?

To start investing in Jasper Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Jasper Therapeutics Stock (JSPR)?

Today’s highest price of Jasper Therapeutics (JSPR) is $5.82.

Today’s lowest price of Jasper Therapeutics (JSPR) is $5.58.

What is today's market capitalisation of Jasper Therapeutics?

Today's market capitalisation of Jasper Therapeutics JSPR is 83.0M

What is the 52 Week High and Low Range of Jasper Therapeutics Stock (JSPR)?

  • 52 Week High

    $31.01

  • 52 Week Low

    $4.55

What are the historical returns of Jasper Therapeutics (JSPR)?

  • 1 Month Returns

    -10.95%

  • 3 Months Returns

    -71.12%

  • 1 Year Returns

    -79.44%

  • 5 Years Returns

    -95.49%

Who is the Chief Executive Officer (CEO) of Jasper Therapeutics ?

Mr. Ronald A. Martell is the current Chief Executive Officer (CEO) of Jasper Therapeutics.